arrow
A

Alexander G. Raufi

brown university
H指数:14
被引数:945

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager

通过携带双特异性T细胞结合剂的溶瘤腺病毒修饰其微环境,实现在胶质母细胞瘤中启用CAR T细胞免疫疗法

2026-06-180
OAAI
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma

与转移性器官趋向性和胰腺导管腺癌患者生存相关的细胞状态

2025-10-270
PRE
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer

II期研究评估elraglusib(9-ING-41),一种GSK-3β抑制剂,与吉西他滨联合nab-紫杉醇用于既往未治疗的转移性胰腺癌。

2025-06-010
OA
Integrated clinical and single-cell profiling analysis reveals cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma
2024-09-150
PRE
Targeting apoptotic pathways for cancer therapy
2024-07-154
OAAI
CheMo4METPANC: Combination Chemotherapy ( gemcitabine and nabpaclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in METastatic treatment-naive PANCreatic adenocarcinoma
2024-01-160
PRE